Henry Ford Health System, Detroit, USA
Internationally renowned breast cancer surgeon Lisa A. Newman, M.D., MPH, has joined Henry Ford Health System to lead its metro Detroit breast cancer program and new international breast cancer research center. Her most recent position was Professor of Surgery and Director of the Breast Care Center at the University of Michigan.
Dr. Newman obtained her undergraduate education and Masters Degree in Public Health from Harvard University. She attended medical school and completed her general surgery residency training at the State University of New York Health Science Center at Brooklyn. She completed her fellowship in surgical oncology at the M.D. Anderson Cancer Center in Houston, Texas.
Her extensive research related to disparities in breast cancer risk and outcome has been published in numerous peer-reviewed medical journals and was recently featured on CNN’s documentary “Black in America 2”. She holds leadership positions with the Society of Surgical Oncology (Executive Council; Disparities Committee Chair), the American Society of Clinical Oncology (former Chair, Health Services Committee; current Chair, Disparities Advisory Board) and serves as editorial section editor for the journals Cancer (Disparities Section Editor) and Annals of Surgical Oncology (Breast Section Editor). She also serves on the editorial boards for CA- A Cancer Journal for Clinicians; Journal of Clinical Oncology; and Breast Cancer Research and Treatment. She also serves on the Breast Prevention Section of the National Comprehensive Cancer Network. She maintains a very active community service record, and currently serves as Chief National Medical Advisor for the Sisters Network, Inc., a national African American breast cancer survivors support organization.
Dr. Newman’s primary research has focused on ethnicity-related variation in breast cancer risk and outcome, the evaluation and management of high-risk patients (including ductal lavage); broadened applications for induction chemotherapy, and special surgical techniques such as the skin-sparing mastectomy and lymphatic mapping/sentinel lymph node biopsy. Her basic science research has involved investigations of p27 and Her2/neu in breast cancer.